Literature DB >> 7888104

Excitotoxicity. Experimental correlates to human epilepsy.

K G Haglid1, S Wang, Y Qiner, A Hamberger.   

Abstract

Neurochemical observations on cortical biopsies form 48 patients under surgical treatment for pharmacoresistant partial epilepsy showed a 70-80% increase in glutamate concentration when expressed in relation to neuron specific enolase. Intraperitoneal administration of one of its receptor agonists, kainic acid (KA), to the rat led to increased epileptogenic activity of the limbic type in a dose-dependent fashion. The KA injection also led to a neuronal cell death and a gliosis, closely correlated to the extent of seizure activity. In biopsies from human epileptogenic cortex, the concentration of neuron specific enolase correlated inversely to that of glial fibrillary acidic protein, a marker for astrocytic glial cells. Stimulation of the KA receptor decreased the extent of phosphorylation of the largest subunit of neurofilaments (NF-H) that have consequences for structural stability and axonal transport. Phosphorylated NF-H decreased also in human epileptic cortex, indicating either an overactivity of excitatory neurotransmitters or a loss of axonal compartments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888104     DOI: 10.1007/BF02816125

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  20 in total

1.  Excitatory amino acids are elevated in human epileptic cerebral cortex.

Authors:  A Sherwin; Y Robitaille; F Quesney; A Olivier; J Villemure; R Leblanc; W Feindel; E Andermann; J Gotman; F Andermann
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

2.  Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2.

Authors:  S Halpain; P Greengard
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

3.  Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns.

Authors:  M J Carden; J Q Trojanowski; W W Schlaepfer; V M Lee
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

4.  Glial contribution to seizure: K+ activation of (Na+, K+)-ATPase in bulk isolated glial cells and synaptosomes of epileptogenic cortex.

Authors:  T Grisar; G Franck; A V Delgado-Escueta
Journal:  Brain Res       Date:  1983-02-14       Impact factor: 3.252

5.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

Authors:  L A Sternberger; N H Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats.

Authors:  V M Lee; M J Carden; W W Schlaepfer; J Q Trojanowski
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

Review 7.  Cytoskeletal protein abnormalities in neurodegenerative diseases.

Authors:  J E Goldman; S H Yen
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

8.  Abnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid.

Authors:  J Hugon; J M Vallat
Journal:  Neurosci Lett       Date:  1990-10-30       Impact factor: 3.046

9.  "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies.

Authors:  R S Sloviter
Journal:  Brain Res Bull       Date:  1983-05       Impact factor: 4.077

10.  Excitotoxic mechanisms of epileptic brain damage.

Authors:  J W Olney; R C Collins; R S Sloviter
Journal:  Adv Neurol       Date:  1986
View more
  13 in total

1.  De Novo Mutations in YWHAG Cause Early-Onset Epilepsy.

Authors:  Ilaria Guella; Marna B McKenzie; Daniel M Evans; Sarah E Buerki; Eric B Toyota; Margot I Van Allen; Mohnish Suri; Frances Elmslie; Marleen E H Simon; Koen L I van Gassen; Delphine Héron; Boris Keren; Caroline Nava; Mary B Connolly; Michelle Demos; Matthew J Farrer
Journal:  Am J Hum Genet       Date:  2017-08-03       Impact factor: 11.025

Review 2.  Status epilepticus: pathophysiology, epidemiology, and outcomes.

Authors:  R C Scott; R A Surtees; B G Neville
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

Review 3.  Metabolic parameters of epilepsy: adjuncts to established antiepileptic drug therapy.

Authors:  Nico M van Gelder; Allan L Sherwin
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

Review 4.  What are the effects of prolonged seizures in the brain?

Authors:  Rod C Scott
Journal:  Epileptic Disord       Date:  2014-10       Impact factor: 1.819

5.  Insights into the development of pentylenetetrazole-induced epileptic seizures from dynamic metabolomic changes.

Authors:  Xue Zhao; Peixuan Cheng; Ru Xu; Kaili Meng; Sha Liao; Pu Jia; Xiaohui Zheng; Chaoni Xiao
Journal:  Metab Brain Dis       Date:  2022-07-15       Impact factor: 3.655

Review 6.  The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders.

Authors:  Sahar Alijanpour; Mohammad Miryounesi; Soudeh Ghafouri-Fard
Journal:  Metab Brain Dis       Date:  2022-09-29       Impact factor: 3.655

7.  Status epilepticus: Using antioxidant agents as alternative therapies.

Authors:  Liliana Carmona-Aparicio; Cecilia Zavala-Tecuapetla; María Eva González-Trujano; Aristides Iii Sampieri; Hortencia Montesinos-Correa; Leticia Granados-Rojas; Esaú Floriano-Sánchez; Elvia Coballase-Urrutía; Noemí Cárdenas-Rodríguez
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

8.  PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling.

Authors:  Ming Li; Fenghe Niu; Xilin Zhu; Xiaopan Wu; Ning Shen; Xiaozhong Peng; Ying Liu
Journal:  Int J Mol Sci       Date:  2015-04-23       Impact factor: 5.923

9.  New mechanism for glutamate hypothesis in epilepsy.

Authors:  Chang-Hoon Cho
Journal:  Front Cell Neurosci       Date:  2013-08-13       Impact factor: 5.505

10.  Dental pulp stem cells for treating neurodegenerative diseases.

Authors:  Christopher Shamir; Chaitra Venugopal; Anandh Dhanushkodi
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.